Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Steve Lombardi, Nicole DeBerg, Andrea Califano, Arnold Levine, Aviv Regev, More


Nabsys has appointed Steve Lombardi to president, CEO, and to its board of directors. Previously, he was CEO of Real Time Genomics, and before that, he was CEO of Helicos BioSciences. He has also served as senior vice president of Affymetrix and vice president of genetic analysis at Applied Biosystems.

The J. Craig Venter Institute has hired Nicole DeBerg as chief operating officer. Previously, she was CFO and vice president of financial services at the San Diego Housing Commission. Prior to that, she held financial leadership positions at several emerging biotechnology companies, including Altair Therapeutics, Kalypsys, and Depotech. She was also CFO at the Sanford-Burnham Medical Research Institute.

Thermo Fisher Scientific has appointed Andrea Califano, Arnold Levine, and Aviv Regev to its scientific advisory board.

Califano is founding chairman of the department of systems biology at Columbia University and he currently serves on th board of scientific advisors at the National Cancer Institute.

Levine is professor emeritus of systems biology at the Institute for Advanced Study and professor of pediatrics and of biochemistry with the Robert Wood Johnson Medical School at Rutgers, the State University of New Jersey.

Regev is a core member of the Broad Institute and an associate professor of biology at the Massachusetts Institute of Technology. She is also an investigator at the Howard Hughes Medical Institute.

Agilent has appointed Alessandro Borsatti to senior director of product marketing and scientific affairs. He has had various roles at Agilent since joining the company in February 2013. Before that, he was global business director of molecular diagnostics at PerkinElmer. Agilent has also appointed Rebecca Brandes to global marketing director of molecular pathology. She is a co-founder of Prairie Fire Labs and was also the owner and executive vice president of sales and marketing at i.d.i consulting and Celerity Marketing Group.

The Scan

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.